Navigation Links
Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System (AFRS(TM))

LOGAN, Utah, Oct. 19 /PRNewswire/ -- Facet Solutions, Inc. announced today that John Regan, M.D., a board-certified orthopedic surgeon at Century City Doctors Hospital in Los Angeles, California; and Darryl DiRisio, M.D., associate professor and neurosurgeon at Albany Medical College, Albany, New York, successfully completed additional surgical procedures utilizing the company's Anatomic Facet Replacement System (AFRS(TM)) as part of an FDA approved IDE Clinical Trial.

The AFRS(TM) is the first anatomic facet replacement device designed to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to fusion.

A fusion uses metal rods and screws to join vertebrae together. While most patients report pain relief after a spinal fusion, the surgery often eliminates flexibility and range of motion, and can cause unnecessary wear on other spinal levels. By contrast, the AFRS(TM) is designed to mimic normal motion and prevent adjacent level degeneration.

The AFRS(TM) is made of two highly polished cobalt chrome implants that articulate similar to other total joints that have been used successfully in hip and knee replacements for several decades

"Until recently, people suffering from chronic lower back pain caused by lumbar spinal stenosis had few treatment options," stated Dr. Regan. "Facet joint replacement utilizing the AFRS(TM) not only relieves low back pain but also has the potential to significantly improve the patients' flexibility and range of motion.

Dr. DiRisio noted that the use of facet joint replacement for the treatment of spinal stenosis following a spinal decompression is a notable advance in spinal surgery. "It offers surgeons an alternative treatment for patients who have suffered for years from this debilitating condition."

The public response overall to the AFRS(TM) clinical trial has been very strong. New clinical investigator, Kenneth Pettine, M.D., board-certified orthopedic surgeon with the Rocky Mountain Spine Arthoplasty Specialists in Loveland, Colorado is looking forward to offering this new treatment option to his patients.

"Recently, I hosted a local community presentation to educate patients on the advantages of this new technology," stated Dr. Pettine. "I was very pleased with the strong attendance and was encouraged that a third of the attendees had signed up to learn more about the AFRS(TM) trial. The potential for patients to maintain motion, and continue with the normal activities of daily living, is what I believe is driving the high level of interest in this trial."

Facet Solutions invites clinicians, medical facilities, and other interested parties to visit for specific information about the AFRS(TM) Clinical Trial.

Facet Solutions also invites patients who are interested in learning more about the AFRS(TM) clinical trial to visit To determine if they are eligible to participate in the trial, patients can also call 1-877-STUDY-25.

*Note: AFRS(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture backed company that is focused on developing and commercializing surgical devices for the treatment of facet related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.

SOURCE Facet Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
2. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. Genetic Analysis Systems Enter the Clinical Mainstream
5. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
6. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
7. Sygnis Pharma AG announces date for presentation of clinical results
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Today AVACEN Medical announced the issue of United ... Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat therapy ... Method. Photo - ... ... ...
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) today ... will discuss corporate updates at the 27 th Annual ... on Wednesday, December 2, 2015 at 1 p.m. ET. ... then the link to the event. Participants should allow approximately ... the site and download any streaming media software needed to ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... As ... Water For Empowerment ™ attracts volunteers together who want to combine talents and ... as key stakeholders in the process. The non-profit launched its first major fundraiser ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless ... treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, ... without the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X ... Products explains what this means for business moving forward. , The Tri Lite heater ... model: to sell personal heaters that reduce energy consumption, are economical and keep people ...
(Date:11/25/2015)... ... 2015 , ... In an ongoing Clinical Study conducted by an independent physician, ... Angel is evaluating the efficacy of its product and its disinfection protocol. This study ... from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located ...
Breaking Medicine News(10 mins):